Humacyte Inc is a biotechnology company focused on developing and commercializing innovative regenerative medicine products, specifically human acellular vessels (HAVs) designed for use in vascular surgeries

The company utilizes its proprietary tissue engineering platform to create off-the-shelf, biocompatible vessels that can address the limitations of traditional grafts in treating various vascular conditions. Humacyte aims to improve patient outcomes by providing solutions that enhance the healing process, reduce the risk of complications, and ultimately expand access to life-saving surgical treatments.